发明名称 |
METHOD FOR ALTERING UNDESIRABLE IMMUNE RESPONSES TO POLYPEPTIDES |
摘要 |
The disclosed method involves providing a collection of mutant polypeptides where the amino acid sequence of each mutant polypeptide differs in at least one position from a polypeptide of interest, identifying mutant polypeptides that exhibit less of the immune response than the polypeptide of interest, a nd identifying mutant polypeptides with less potential for eliciting an undesirable immune response that still retain the desired characteristic(s). The collection of mutant polypeptides can be provided by mutagenizing nuclei c acid encoding a polypeptide of interest and expressing the mutagenized nucle ic acid to produce mutant polypeptides. The method is especially useful for reducing immune responses involving both linear and/or conformational epitop es on a polypeptide of interest. This is possible because the recombinant polypeptides used as substrates for mutagenesis in the method are essentiall y full length, remaining structurally similar to the polypeptide of interest a nd displaying essentially the same conformational epitopes.
|
申请公布号 |
CA2362368(A1) |
申请公布日期 |
2000.08.17 |
申请号 |
CA20002362368 |
申请日期 |
2000.02.10 |
申请人 |
PANACEA PHARMACEUTICALS, LLC |
发明人 |
CAPLAN, MICHAEL |
分类号 |
A01H5/00;A01K67/027;A61K38/00;A61K45/00;A61P37/02;C07K14/435;C07K19/00;C12N15/01;C12N15/09;G01N33/15;G01N33/50;G01N33/53;G01N33/68;G01N37/00;(IPC1-7):G01N33/68;A61K39/35;C07K14/00;C12N15/82 |
主分类号 |
A01H5/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|